HIGHLIGHTS
- who: Phillip O. Coffin and collaborators from the University of California San Francisco, San Francisco, California, United States of America, University of have published the article: Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0217471]. June 3, 2019 of February/12,/2019
- what: The authors focused on those who were actively injecting with other people present to ensure the authors were reaching people who could be at risk for transmitting HCV to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.